RYBOX
Rydex Biotechnology A
NasdaqUSDEQUITY
DELAYED
Neutral
+19/100
Last price
76.01
▼ 1.70 (2.19%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
77.71
Day high
—
Day low
—
Volume
—
Market cap
—
P/E (TTM)
—
52W range
59.34 – 81.29
Trailing performance
Returnvs SPY
1W
-3.28%
-5.2%
1M
-4.00%
-5.5%
3M
+0.38%
-3.0%
6M
+21.31%
+6.3%
YTD
+23.15%
+9.2%
1Y
+18.80%
+3.1%
3Y
+33.21%
-48.7%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Free account
3 more panels on RYBOX open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
77.73
-2.21% from price
SMA 20
77.46
-1.87% from price
SMA 50
76.86
-1.10% from price
SMA 100
73.05
+4.05% from price
SMA 200
68.09
+11.63% from price
EMA 12
77.46
-1.88% from price
EMA 26
77.47
-1.89% from price
EMA 50
76.44
-0.56% from price
RSI (14)
43.3
Neutral
MACD (12,26,9)
-0.01
Hist -0.26
ATR (14)
0.85
1.12% of price
Realised vol 30D
19.9%
Annualised
Bollinger upper
79.34
20, 2σ
Bollinger lower
75.58
20, 2σ
50 / 200 cross
Golden
76.86 vs 68.09
Trend bias
Above 200
+11.63%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.01
Less volatile than market
Correlation to SPY
0.01
Largely independent
Realised vol 30D
19.9%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-18.4%
Peak to trough
Max drawdown 5Y
-49.4%
Peak to trough
ATR 14
0.85
1.12% of price
Beta (reported)
—
5Y monthly, from filing
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.